Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observatory of Patients With MyeloProliferative Neoplasm Treated With Anti-inflammatory Immunotherapy

NCT06476535 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.

NCT NCT06476535
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06476535 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observatory of Patients With MyeloProliferative Neoplasm Treated With Anti-inflammatory Immunotherapy
Lead sponsor
University Hospital, Brest
Phase
Observational
Overall status
Unknown status
Start date
June 11, 2024
Completion date
May 31, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory disease, myeloproliferative neoplasm